Jeremy Grantham (GMO) disclosed new in LARIMAR THERAPEUTICS INC

Jeremy Grantham (GMO) filed a 13F change in LARIMAR THERAPEUTICS INC (517125100) on 2026-05-14, covering period end 2026-03-31.

Action

New

Capital

$58,793 reported value

Why it matters

This signal is anchored to the SEC filing date while retaining the underlying 13F period end.

Jeremy Grantham (GMO) filed a 13F change in HP INC (40434L105) on 2026-05-14, covering period end 2026-03-31.

Jeremy Grantham (GMO) filed a 13F change in 50212V100 (50212V100) on 2026-05-14, covering period end 2026-03-31.